You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
东风股份(601515.SH)拟1.35亿元收购首键药包75%股权
格隆汇 09-07 19:00

格隆汇9月7日丨东风股份(601515.SH)公布,公司与唐光文、重庆市康慧恒企业管理中心(有限合伙)及重庆首键药用包装材料有限公司签署《关于收购重庆首键药用包装材料有限公司75%股权之股权转让协议》,以人民币1.35亿元的价格受让唐光文持有的重庆首键药用包装材料有限公司75%股权。

药品包装(包括直接接触药品的一级内包装)是印刷包装行业的细分领域,作为最大的新兴医药市场体,伴随着经济的持续高速增长,我国医药产业近年来增长较快。

公司本次拟同时收购首键药包75%股权及常州市华健药用包装材料有限公司(以下简称“华健药包”)70%股权,并实现对两家公司的控股,首键药包及华健药包均为原新三板挂牌企业,在行业内具备较强的规模及实力。首键药包主要从事I类医药用瓶盖研发、生产、销售,主要产品包括口服液、输液瓶用易刺铝盖、铝塑组合盖和撕拉铝盖等产品,华健药包主要生产I类药用包装铝箔、SP复合膜、成型冲压复合硬片(冷冲压成型铝、热带泡罩铝)材料,两者与千叶药包在产品品类上相互补充,进一步拓展公司医药包装业务的产品类别,并通过千叶药包、首键药包及华健药包在生产、销售及客户资源上的有效协同,有望进一步做强做大公司的医药包装业务板块,提升公司印刷包装产业板块的整体规模及市场竞争力,加快推进“大包装与大消费产业双轮驱动发展”战略的实施。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account